# Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases

> **NCT02517385** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 147 (actual)

## Conditions studied

- Hepatic and Hepatobiliary Disorders

## Interventions

- **DRUG:** Phosphatidylcholine

## Key facts

- **NCT ID:** NCT02517385
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2016-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517385, "Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02517385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*